Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer
Clinical Lung Cancer · 2025-05 · 26 (3) · 168-178
DOI: 10.1016/j.cllc.2025.02.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Lung Cancer, 2025-05. Verfasst von Luis Paz-Ares und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario 12 de Octubre, H120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc, Madrid, Spain. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Maintenance Chemotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Jazz Pharmaceuticals.
Abstract (Originalsprache)
Small cell lung cancer (SCLC) is a highly aggressive malignancy and an exceptionally lethal disease; most patients present with extensive stage (ES) disease at diagnosis. Very little had changed in the treatment of ES-SCLC for decades until immune checkpoint inhibitor (ICI) therapy combined with chemotherapy followed by ICI maintenance monotherapy was added to standard treatment paradigms in 2019. Despite this important advance, high rates of relapse are still observed in patients with ES-SCLC and long-term survival rates remain low, with approximately 40% of patients proceeding to receive second-line treatment. There is an urgent need for novel treatment strategies to improve patient outcomes. In this review, we describe the rationale for maintenance therapy approaches in ES-SCLC and summarize the existing data on chemotherapy, ICIs, and other agents in the first-line maintenance setting. Predictive biomarkers, SCLC subtypes, and new therapeutics in development are discussed including lurbinectedin, antibody-drug conjugates, and T-cell engager molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario 12 de Octubre, H120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc, Madrid, Spain.
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. Electronic address: stephen.liu@gunet.georgetown.edu.
Förderung
- Jazz Pharmaceuticals
Zitieren
APA
Paz-Ares, L., Gupta, B., Baena, J., & Liu, S. V. (2025). Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer, 26(3), 168-178. https://doi.org/10.1016/j.cllc.2025.02.015
Vancouver
Paz-Ares L, Gupta B, Baena J, Liu SV. Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 2025;26(3):168-178. doi:10.1016/j.cllc.2025.02.015
BibTeX
@article{PazAres2025,
author = {Paz-Ares, Luis and Gupta, Brinda and Baena, Javier and Liu, Stephen V},
title = {Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer},
journal = {Clinical Lung Cancer},
year = {2025},
volume = {26},
number = {3},
pages = {168--178},
doi = {10.1016/j.cllc.2025.02.015}
}
EUVIMED